FDA Reform Legislation Emerges as Exception to Washington Gridlock
This article highlights the bipartisan nature of the user fee reauthorization legislation and quotes Catalyst President Nancy Myers on the similarities between the House and Senate versions: "I would say it's pretty surprising how significantly they lined up," she says in the article. "The politicians realized that each one of these user fee agreements had